BUSINESS
Questions raised over J&J's India-specific donation of TB drug bedaquiline
The US-based healthcare products major is already facing multiple regulatory investigations in the country over the safety of its products.
BUSINESS
Glenmark launches cheaper SGLT2 inhibitor class of anti-diabetes drug in India
The drug, generically called as Remogliflozin etabonate, is used in the treatment of type-2 diabetes mellitus in adults.
BUSINESS
Ball in Medanta's court, following Manipal-TPG's Rs 5,800-cr acquisition bid
Manipal and TPG entered into negotiations with heart surgeon Naresh Trehan and other investors in October 2018 to acquire their stake in Medanta.
BUSINESS
Why India shouldn't bow down to US pressure on legitimate IPR flexibilities
India has been clubbed along with countries such as Algeria, Argentina, Chile, China, Indonesia, Kuwait, Russia, Saudi Arabia, Ukraine and Venezuela in the USTR Priority Watch List.
BUSINESS
Piramal says only eyeing home loan portfolio of DHFL, not its shares
Piramal has been trying to cut exposure to wholesale real estate lending exposure. The company had reduced lending to real estate from 83 percent in March 2015 to 63 percent in March 2019, and plans to further bring it down to 50 percent by the end of this year.
BUSINESS
Riding on biosimilar sales, Biocon Q4 profit up 64% at Rs 214 crore
Total revenue during the quarter grew by 26 percent to Rs 1,557 crore.
BUSINESS
Clinivantage helps small hospitals and clinics in digital transformation
Jain said the entire platform can be accessed for as low as Rs 50 per patient per entire year for a small hospital.
BUSINESS
Top pharma companies eyeing Bharat Serums and Vaccines
Focus on R&D, technical competence, niche and complex product portfolio are some of the factors that make BSV as attractive proposition for PE investors and pharma companies.
BUSINESS
As RBI and Kotak Bank spar over promoter stake rule, experts feel spirit of law at stake
While the Bombay High Court has “no time” to address the case before 2020, market experts have strong opinions about Kotak’s defiance against the RBI.
BUSINESS
Medlife crosses Rs 1000 crore sales, expects 50% growth in FY20
The company's pharmacy segment showed grew three times from last year and the lab vertical contributed to about Rs 40 to 45 crore of the revenue.
BUSINESS
Govt proposal to allow dentists to practice general medicine evokes mixed response
The government wants to channelize dental graduates who are in excess to serve primary healthcare needs of rural and semi-urban areas, where there is shortage of MBBS doctors.
BUSINESS
Jet Airways employees seek Prime Minster's intervention to solve their woes
All India Jet Airways Officers & Staff Association (AIJAOSA), that’s representing the employees of beleaguered Jet Airways wrote a letter seeking the intervention of Prime Minister Narendra Modi, to resolve the ensuing crisis at the debt-laden airlines.
BUSINESS
Reminiscing old days, crestfallen Jet Airways employees clinging on to hope
While a growing Indian aviation market means that there are jobs on offer, the prospect is not as bright for everyone in the airline.
POLITICS
In new Andhra capital Amaravati, farmers fear uncertainty if CM Chandrababu Naidu loses power
YSRCP chief Jagan Mohan Reddy has maintained stoic silence on Amaravati in his election manifesto or rallies
BUSINESS
Evonik Industries commissions catalysts plant near Mumbai for pharma industry
The new manufacturing unit in Dombivli, Mumbai will greatly enhance supply with high quality catalysts for the Asia Pacific region, in addition to exports to South East Asia markets.
BUSINESS
Emcure launches knock-off of Eisai's cancer drug Halaven at 40% lower price in India
Emcure is confident of overcoming any patent challenge by the innovator, as it claims its version is developed through a non-infringing process.
BUSINESS
Sudarshan Jain, former Abbott top executive, is IPA Secretary General
The appointment of Jain follows the demise of DG Shah in February.
BUSINESS
Cipla's HR head Prabhir Jha quits, floats advisory firm
Jha on his Linkedin announced that he will be starting a new journey launching advisory venture called Prabir Jha People Advisory, where he will be helping companies on people's practices
BUSINESS
Cardiac stents price to rise by 8% YoY
Drug eluting stents or the stents coated with a drug, constitutes 95 percent of the market
HEALTH-TRENDS
How our political discourse stigmatises mental health
Stigmatization of mental illness, becomes a major barrier for people with mental health problems to seek professional help, as they fear being labelled and bullied.
BUSINESS
Delhi police files criminal case against Singh brothers for causing Rs 2,397 crore loss to Religare
Earlier this month stock market regulator the Securities and Exchange Board of India (SEBI) has directed Religare Enterprises and Religare Finvest to recover loans worth Rs 2,315.09 crore from the Singh brothers and entities related to them.
BUSINESS
Adani Group may join race to acquire GMR's Kakinada SEZ and port
GMR owns 51 percent in Kakinada SEZ Ltd which is developing a multi-product SEZ spanning over 10,000 acres, near Kakinada, in addition to having a license to build a multipurpose all weather deep draft port, as part of SEZ at an investment of Rs 2,123 crore.
BUSINESS
New clinical trial rules to boost growth of clinical research industry
The New Drugs and Clinical Trial Rules state the any drug discovered in India and proposed to be manufactured and marketed in India, will be deemed approval for clinical trials in 30 working days, if no communication received from the Central Licensing Authority (CLA).
BUSINESS
GMR to spin-off airports business, eyes profitability in FY20
GMR on March 27 said it has signed a binding term sheet with a consortium of a Tata Group company, Singapore's sovereign wealth fund GIC and SSG Capital Management for raising Rs 8,000 crore in its airports business.
